These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31025496)

  • 1. A Panel of Three Biomarkers Identified by iTRAQ for the Early Diagnosis of Pancreatic Cancer.
    Wu X; Zhang ZX; Chen XY; Xu YL; Yin N; Yang J; Zhu DM; Li DC; Zhou J
    Proteomics Clin Appl; 2019 Sep; 13(5):e1800195. PubMed ID: 31025496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-Binding Motif Protein 6 is a Candidate Serum Biomarker for Pancreatic Cancer.
    Duan B; Hu X; Fan M; Xiong X; Han L; Wang Z; Tong D; Liu L; Wang X; Li W; Yang J; Huang C
    Proteomics Clin Appl; 2019 Sep; 13(5):e1900048. PubMed ID: 31207145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline.
    Liu X; Zheng W; Wang W; Shen H; Liu L; Lou W; Wang X; Yang P
    Br J Cancer; 2017 Dec; 117(12):1846-1854. PubMed ID: 29123261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach.
    Park J; Lee E; Park KJ; Park HD; Kim JW; Woo HI; Lee KH; Lee KT; Lee JK; Park JO; Park YS; Heo JS; Choi SH; Choi DW; Jang KT; Lee SY
    Oncotarget; 2017 Jun; 8(26):42761-42771. PubMed ID: 28514751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic system alterations in pancreatic cancer patient serum: potential for early detection.
    Ritchie SA; Akita H; Takemasa I; Eguchi H; Pastural E; Nagano H; Monden M; Doki Y; Mori M; Jin W; Sajobi TT; Jayasinghe D; Chitou B; Yamazaki Y; White T; Goodenowe DB
    BMC Cancer; 2013 Sep; 13():416. PubMed ID: 24024929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study.
    Kaur S; Smith LM; Patel A; Menning M; Watley DC; Malik SS; Krishn SR; Mallya K; Aithal A; Sasson AR; Johansson SL; Jain M; Singh S; Guha S; Are C; Raimondo M; Hollingsworth MA; Brand RE; Batra SK
    Am J Gastroenterol; 2017 Jan; 112(1):172-183. PubMed ID: 27845339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics.
    Hirata Y; Kobayashi T; Nishiumi S; Yamanaka K; Nakagawa T; Fujigaki S; Iemoto T; Kobayashi M; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Yamada T; Honda K; Azuma T; Yoshida M
    Clin Chim Acta; 2017 May; 468():98-104. PubMed ID: 28215548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
    Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
    Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
    Xiong Y; Shi C; Zhong F; Liu X; Yang P
    Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.
    Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L
    Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques.
    Velstra B; Vonk MA; Bonsing BA; Mertens BJ; Nicolardi S; Huijbers A; Vasen H; Deelder AM; Mesker WE; van der Burgt YE; Tollenaar RA
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):531-41. PubMed ID: 25240825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Validation of Biomarkers That Distinguish Mucinous and Nonmucinous Pancreatic Cysts.
    Park J; Yun HS; Lee KH; Lee KT; Lee JK; Lee SY
    Cancer Res; 2015 Aug; 75(16):3227-35. PubMed ID: 26122842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible proteomic biomarkers for the detection of pancreatic cancer in oral fluids.
    Deutsch O; Haviv Y; Krief G; Keshet N; Westreich R; Stemmer SM; Zaks B; Navat SP; Yanko R; Lahav O; Aframian DJ; Palmon A
    Sci Rep; 2020 Dec; 10(1):21995. PubMed ID: 33319845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
    Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
    EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry.
    Wang Y; Kuramitsu Y; Yoshino S; Takashima M; Zhang X; Ueno T; Suzuki N; Oka M; Nakamura K
    Oncol Rep; 2011 Jul; 26(1):287-92. PubMed ID: 21519797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.
    Gao J; Zhu F; Lv S; Li Z; Ling Z; Gong Y; Jie C; Ma L
    Oncol Rep; 2010 Jun; 23(6):1683-92. PubMed ID: 20428826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry-based iTRAQ analysis of serum markers in patients with pancreatic cancer.
    Jia K; Zhao X; Dang X
    Oncol Lett; 2020 Jun; 19(6):4106-4114. PubMed ID: 32382349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytically validated protein biomarkers of chronic pancreatitis and pancreatic cancer for potential clinical diagnosis with mass spectrometry.
    Chou CY; Chang CT; Chen CJ
    Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8580. PubMed ID: 31502717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer.
    Yang J; Zhang Y; Gao X; Yuan Y; Zhao J; Zhou S; Wang H; Wang L; Xu G; Li X; Wang P; Zou X; Zhu D; Lv Y; Zhang S
    Front Oncol; 2021; 11():628346. PubMed ID: 34026608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pancreatic Cancer.
    Li H; Mao Y; Xiong Y; Zhao HH; Shen F; Gao X; Yang P; Liu X; Fu D
    Cancer Genomics Proteomics; 2019; 16(1):81-89. PubMed ID: 30587502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.